Medacta Sustainability Profile
Medacta International SA, headquartered in Switzerland (CH), is a leading player in the global medical device industry, specialising in orthopaedic and spinal surgery solutions. Founded in 1999, the company has established a strong presence in key operational regions, including Europe, North America, and Asia. Medacta is renowned for its innovative products, such as the M.O.R.E. (Medacta Orthopaedic Research and Education) programme, which enhances surgical techniques and patient outcomes. The company’s commitment to advanced technology and minimally invasive procedures sets it apart in the competitive landscape. With a focus on quality and precision, Medacta has achieved significant milestones, including numerous regulatory approvals and a growing portfolio of patented technologies. Its dedication to improving surgical performance and patient care solidifies its position as a trusted name in orthopaedics and spinal surgery.
DitchCarbon Score
How does Medacta's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medacta's score of 30 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medacta's reported carbon emissions
In 2024, Medacta, headquartered in Switzerland (CH), reported total carbon emissions of approximately 1,916,000 kg CO2e globally. This figure includes 1,296,000 kg CO2e from Scope 1 emissions and 620,000 kg CO2e from Scope 2 emissions, with a market-based approach accounting for 321,000 kg CO2e. Notably, in Switzerland, the company recorded Scope 2 emissions of about 41,000 kg CO2e. Medacta has not disclosed any specific reduction targets or initiatives as part of its climate commitments. The absence of SBTi (Science Based Targets initiative) reduction targets indicates that the company has not yet established formalised goals for reducing its carbon footprint. Furthermore, there are no significant climate pledges or reduction initiatives reported. The emissions data is sourced directly from Medacta Group SA, with no cascading from a parent or related organisation. As the company continues to navigate its sustainability journey, it remains essential for Medacta to develop and communicate clear climate commitments to align with industry standards and expectations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 500,000 | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 | 0,000,000 |
| Scope 2 | - | - | - | - | - | - | 000,000 | 000,000 |
| Scope 3 | - | - | - | - | - | - | - | - |
How Carbon Intensive is Medacta's Industry?
How Carbon Intensive is Medacta's Location?
Medacta's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medacta has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
